Sriram Ryali - Chief Financial Officer at Eiger BioPharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
EIGRQ on OTC
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sriram Ryali since 11/5/2023

Holdings reported by Sriram Ryali for Eiger BioPharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 41.6K $12.4K $0.30 Mar 14, 2022 Direct
Stock Option (Right to Buy) 143K Mar 11, 2022 Direct Common Stock

Transactions reported by Sriram Ryali for Eiger BioPharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.